Drug Profiles

● Vyvanse

Vyvanse

lisdexamfetamine dimesylate

  • Drug Class CNS Stimulant — Prodrug Amphetamine
  • Manufacturer Takeda Pharmaceuticals (brand); generics available
  • Forms Available Capsules only (can be dissolved in water)
  • Available Strengths 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
  • FDA Indications ADHD (adults & children 6+); Binge Eating Disorder (adults)
  • Schedule DEA Schedule II
  • Typical Duration 10–14 hours
● Adderall

Adderall

mixed amphetamine salts

  • Drug Class CNS Stimulant — Mixed Amphetamine Salts
  • Manufacturer Teva / Shire (brand); widely generic
  • Forms Available Immediate-release tablets (IR); Extended-release capsules (XR)
  • Available Strengths IR: 5–30 mg tablets; XR: 5–30 mg capsules
  • FDA Indications ADHD (adults & children 3+); Narcolepsy
  • Schedule DEA Schedule II
  • Typical Duration IR: 4–6 hrs · XR: 8–12 hrs

Mechanism of Action

Both drugs ultimately increase dopamine and norepinephrine activity in the prefrontal cortex. The key distinction is how they get there.

Vyvanse — Prodrug Pathway
IngestedLisdexamfetamine (inactive)
AbsorbedEnters bloodstream via GI tract
ConvertedEnzymes in red blood cells cleave lysine
Actived-Amphetamine released
Because activation requires enzymatic conversion in the bloodstream, the process is self-limiting — the body can only convert so much at once, producing a smoother, more gradual onset and reducing the potential for a rapid euphoric effect.
Adderall — Direct Active Drug
IngestedMixed amphetamine salts (active)
AbsorbedDirectly into bloodstream
Active75% d-amphetamine, 25% l-amphetamine effect begins
Adderall IR reaches peak plasma concentration faster, producing a more noticeable onset. The XR formulation uses beaded technology to release roughly half the dose immediately and half over several hours.

Full Comparison

Feature Vyvanse Adderall
Drug Type Prodrug (inactive until converted) Active drug (works immediately)
Active Ingredient d-Amphetamine (released from lisdexamfetamine) 75% d-amphetamine + 25% l-amphetamine salts
Onset Speed Gradual — ~1–2 hrs to feel effect Faster — IR ~30–60 min; XR ~1–2 hrs
Duration 10–14 hours IR: 4–6 hrs · XR: 8–12 hrs
Forms Capsules only (can open & dissolve) IR tablets & XR capsules
ADHD (adults) ✓ FDA-approved ✓ FDA-approved
ADHD (children) ✓ Ages 6+ ✓ Ages 3+
Binge Eating Disorder ✓ FDA-approved (adults) ✗ Not approved
Narcolepsy ✗ Not approved ✓ FDA-approved
Generic Available ✓ Yes (lisdexamfetamine) ✓ Yes (widely available)
DEA Schedule Schedule II Schedule II
Abuse Potential Lower (prodrug limits rapid delivery) Higher (active drug, faster onset)
Common Side Effects Decreased appetite, insomnia, dry mouth, headache Decreased appetite, insomnia, dry mouth, irritability
Cardiovascular Warning Yes — BP & heart rate monitoring recommended Yes — BP & heart rate monitoring recommended

Key Differences

🔬

Prodrug Design

Vyvanse is inactive as ingested. The body converts it to d-amphetamine via enzymes in red blood cells — a process that is self-limiting and produces a smoother onset. Adderall is immediately pharmacologically active.

⏱

Duration & Coverage

Vyvanse typically provides a single, consistent window of 10–14 hours. Adderall IR requires redosing for similar coverage; Adderall XR reaches 8–12 hours with its two-phase bead release system.

💊

Formulation Flexibility

Adderall comes in both IR tablets (for fine-tuned timing) and XR capsules. Vyvanse is capsules only — but the contents can be opened and dissolved in water or soft food for patients who can't swallow capsules.

⚠️

Abuse & Diversion Risk

Both are Schedule II controlled substances. Vyvanse's prodrug mechanism makes it harder to abuse by non-oral routes, as the conversion process doesn't occur effectively outside the GI tract. This does not mean it carries zero abuse potential.

✅

Binge Eating Disorder

Vyvanse holds an FDA approval for moderate-to-severe binge eating disorder in adults — a distinct indication Adderall does not have. This reflects clinical trial evidence specific to the lisdexamfetamine formulation.

💰

Cost & Generic Access

Both now have generics available. Generic Adderall has been widely available longer and is generally among the most affordable ADHD stimulant options. Generic lisdexamfetamine (Vyvanse) became available more recently.

Frequently Asked Questions

Vyvanse (lisdexamfetamine) is a prodrug that must be converted to active d-amphetamine in the body before it works. This produces a smoother, more gradual onset and makes it harder to abuse. Adderall contains a mixture of active amphetamine salts that take effect more quickly and come in both immediate-release (IR) and extended-release (XR) forms.
No. Both are amphetamine-based stimulants used to treat ADHD, but they are distinct medications. Vyvanse contains lisdexamfetamine, a prodrug the body converts to d-amphetamine. Adderall contains a fixed mixture of four amphetamine salts — approximately 75% dextroamphetamine and 25% levoamphetamine.
Both are Schedule II controlled substances with significant abuse potential, and neither should be considered safe from misuse. Vyvanse's prodrug design means it cannot be rapidly converted to its active form through routes other than oral ingestion, which reduces — but does not eliminate — its abuse potential compared to standard amphetamine formulations. Speak with a clinician about your specific situation.
Yes. According to Vyvanse prescribing information, capsules can be opened and the contents dissolved in water, or mixed into soft foods like yogurt, for patients who have difficulty swallowing capsules. The resulting mixture should be taken immediately. Because Vyvanse is a prodrug that requires oral absorption and enzymatic conversion in the body, dissolving it does not change its pharmacological profile.
Yes. Vyvanse is FDA-approved for moderate-to-severe binge eating disorder (BED) in adults, in addition to ADHD. Adderall is FDA-approved for ADHD and narcolepsy. Neither approval for any of these additional conditions should be taken as a recommendation — only a licensed clinician can determine whether a medication is appropriate for you.
Vyvanse typically provides 10–14 hours of therapeutic coverage due to its prodrug mechanism and the gradual rate of enzymatic conversion. Adderall IR generally lasts approximately 4–6 hours. Adderall XR uses a two-phase bead release system and typically lasts approximately 8–12 hours. Individual response varies.
Combining two amphetamine-based stimulants significantly increases risks including cardiovascular strain, insomnia, and toxicity. This would only be considered in very specific clinical circumstances under close medical supervision. Do not combine these medications without explicit guidance from a prescribing clinician.

Not medical advice. This page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Drug comparisons reflect general pharmacological and regulatory information. Always consult a licensed healthcare provider or pharmacist before starting, stopping, or changing any medication. Both Vyvanse and Adderall are Schedule II controlled substances available only by prescription in the United States.